Disease activity in IBD can be assessed using laboratory markers such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) with sensitivities and specificities ranging between 50% and 60%. The gene discussed is CRP; the disease is inflammatory bowel disease.